Electron Kebebew
#90,517
Most Influential Person Now
Ethiopian-born American surgeon, educator, scientist, academic leader, and health system administrator
Electron Kebebew's AcademicInfluence.com Rankings
Electron Kebebewphysics Degrees
Physics
#5575
World Rank
#7428
Historical Rank
#1649
USA Rank
Biophysics
#205
World Rank
#215
Historical Rank
#43
USA Rank
Electron Kebebewphilosophy Degrees
Philosophy
#6737
World Rank
#9828
Historical Rank
#1558
USA Rank
Logic
#3857
World Rank
#5077
Historical Rank
#740
USA Rank
Download Badge
Physics Philosophy
Electron Kebebew's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Biophysics University of California, San Francisco
Why Is Electron Kebebew Influential?
(Suggest an Edit or Addition)According to Wikipedia, Electron Kebebew is an American surgeon, educator, and scientist. Kebebew is currently the Harry A. Oberhelman Jr. and Mark L. Welton Professor and Chief of General Surgery at Stanford University. Early life and education Electron Kebebew was born in Addis Ababa, Ethiopia on February 26, 1968. Kebebew graduated from the University of California, Los Angeles in 1991 with a B.S. in chemical engineering. In 1995, he graduated with a medicine degree from the University of California, San Francisco where he also went on to do his general surgery residency and postdoctoral fellowship.
Electron Kebebew's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Integrated Genomic Characterization of Papillary Thyroid Carcinoma (2014) (2007)
- Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) (1646)
- Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) (1360)
- American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. (2012) (711)
- Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. (2014) (655)
- Medullary thyroid carcinoma (2000) (594)
- Anaplastic thyroid carcinoma (2005) (528)
- Pathogenic Germline Variants in 10,389 Adult Cancers (2018) (501)
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients (2018) (471)
- The Prevalence and Prognostic Value of BRAF Mutation in Thyroid Cancer (2007) (458)
- Patterns of somatic structural variation in human cancer genomes (2020) (377)
- Extent of Disease at Presentation and Outcome for Adrenocortical Carcinoma: Have We Made Progress? (2006) (361)
- Thyroid cancer gender disparity. (2010) (343)
- Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia. (2012) (340)
- A large multicenter correlation study of thyroid nodule cytopathology and histopathology. (2011) (313)
- Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. (2016) (295)
- Textbook of Endocrine Surgery (1997) (269)
- Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites. (2016) (258)
- Adrenocortical carcinoma in the United States (2008) (257)
- Molecular classification of thyroid nodules using high-dimensionality genomic data. (2010) (252)
- Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. (2016) (241)
- Results of laparoscopic adrenalectomy for suspected and unsuspected malignant adrenal neoplasms. (2002) (241)
- The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society (2017) (222)
- Coexisting Chronic Lymphocytic Thyroiditis and Papillary Thyroid Cancer Revisited (2001) (213)
- Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma (2015) (198)
- Functional thermogenic beige adipogenesis is inducible in human neck fat (2014) (197)
- Comprehensive molecular characterization of mitochondrial genomes in human cancers (2017) (197)
- Localization and reoperation results for persistent and recurrent parathyroid carcinoma. (2001) (190)
- Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context (2018) (188)
- Molecular Testing for Somatic Mutations Improves the Accuracy of Thyroid Fine-needle Aspiration Biopsy (2010) (183)
- Differentiated Thyroid Cancer: “Complete” Rational Approach (2000) (182)
- Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants. (2016) (174)
- MicroRNA profiling of adrenocortical tumors reveals miR‐483 as a marker of malignancy (2011) (174)
- American Thyroid Association Statement on Remote-Access Thyroid Surgery. (2016) (168)
- Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy? (2006) (166)
- The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults. (2020) (164)
- Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. (2011) (158)
- Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model. (2006) (155)
- Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis? (2007) (146)
- Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. (2003) (146)
- Selective Modified Radical Neck Dissection for Papillary Thyroid Cancer—Is Level I, II and V Dissection Always Necessary? (2006) (146)
- American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making. (2015) (143)
- 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer. (2021) (141)
- Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes. (2018) (139)
- 68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI (2016) (138)
- The Aldosteronoma Resolution Score: Predicting Complete Resolution of Hypertension After Adrenalectomy for Aldosteronoma (2008) (137)
- MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer (2012) (134)
- PET/CT comparing 68Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma (2016) (131)
- Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer. (2015) (127)
- Laparoscopic adrenalectomy for malignancy. (2004) (127)
- Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia (2014) (125)
- Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas. (2004) (123)
- ECM1 and TMPRSS4 Are Diagnostic Markers of Malignant Thyroid Neoplasms and Improve the Accuracy of Fine Needle Aspiration Biopsy (2005) (116)
- Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer. (2011) (115)
- Should total thyroidectomy become the preferred procedure for surgical management of Graves' disease? (2005) (114)
- Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors: Current Status and Future Directions (2016) (113)
- Predictors of airway complications after thyroidectomy for substernal goiter. (2004) (112)
- Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer. (2000) (110)
- A phase II trial of rosiglitazone in patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer. (2006) (110)
- Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer. (2009) (110)
- Thyroidectomy for Hashimoto's thyroiditis: complications and associated cancers. (2008) (107)
- Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors. (2015) (106)
- Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling. (2008) (106)
- miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3. (2014) (103)
- Parathyroid adenoma, hyperplasia, and carcinoma: localization, technical details of primary neck exploration, and treatment of hypercalcemic crisis. (1998) (102)
- Management of recurrent/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillance. (2015) (101)
- GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism. (2016) (101)
- Laparoscopic adrenalectomy: the optimal surgical approach. (2001) (98)
- DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumors. (2012) (97)
- Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations. (2010) (97)
- Higher rate of BRAF mutation in papillary thyroid cancer over time (2011) (92)
- Racial disparities in knowledge, attitudes and practices related to COVID-19 in the USA (2020) (91)
- Management of anaplastic thyroid cancer. (2015) (90)
- Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome. (2004) (90)
- Defining a molecular phenotype for benign and malignant parathyroid tumors (2009) (89)
- Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors. (2016) (89)
- Tertiary hyperparathyroidism: histologic patterns of disease and results of parathyroidectomy. (2004) (86)
- Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer In Vitro and In Vivo (2018) (86)
- CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDY. (2016) (85)
- MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors. (2013) (83)
- 68Ga-DOTATATE for Tumor Localization in Tumor-Induced Osteomalacia. (2016) (82)
- Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin. (2013) (82)
- Extent of disease and practice patterns for medullary thyroid cancer. (2005) (81)
- MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets. (2010) (80)
- Primary Aldosteronism and ARMC5 Variants. (2015) (80)
- Does Familial Non-Medullary Thyroid Cancer Adversely Affect Survival? (2006) (79)
- Localization of Insulinoma Using 68Ga-DOTATATE PET/CT Scan (2017) (77)
- Prognostic Indications for Hürthle Cell Cancer (2004) (76)
- Identification of Differentially Expressed MicroRNA in Parathyroid Tumors (2011) (76)
- Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors. (2003) (76)
- Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms (2006) (75)
- Are additional localization studies and referral indicated for patients with primary hyperparathyroidism who have negative sestamibi scan results? (2010) (73)
- Results of rosiglitazone therapy in patients with thyroglobulin-positive and radioiodine-negative advanced differentiated thyroid cancer. (2009) (71)
- Selective Use of Adrenal Venous Sampling in the Lateralization of Aldosterone-producing Adenomas (2006) (71)
- Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples. (2012) (71)
- Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hurthle cell or follicular thyroid cancer. (2008) (70)
- Reasons for Conversion from Laparoscopic to Open or Hand-assisted Adrenalectomy: Review of 261 Laparoscopic Adrenalectomies from 1993 to 2003 (2004) (70)
- Use of the electrothermal vessel sealing system versus standard vessel ligation in thyroidectomy. (2005) (68)
- TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma. (2013) (67)
- Evaluation and management of pancreatic lesions in patients with von Hippel–Lindau disease (2016) (67)
- Tumor Size Predicts Malignant Potential in Hürthle Cell Neoplasms of the Thyroid (2008) (65)
- Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a plea for early surgical referral. (2003) (65)
- Recent developments in the clinical application of thyroid cancer biomarkers (2008) (65)
- Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal disease. (2010) (65)
- miR30a inhibits LOX expression and anaplastic thyroid cancer progression. (2015) (65)
- Clinical and molecular features of papillary thyroid cancer in adolescents and young adults (2011) (65)
- Hook needle-guided excision of recurrent differentiated thyroid cancer in previously operated neck compartments: a safe technique for small, nonpalpable recurrent disease. (2006) (64)
- The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma. (2012) (64)
- Results of (68)Gallium-DOTATATE PET/CT Scanning in Patients with Multiple Endocrine Neoplasia Type 1. (2015) (63)
- Laparoscopic bilateral adrenalectomy: results for 30 consecutive cases (2007) (62)
- MiR-20a Is Upregulated in Anaplastic Thyroid Cancer and Targets LIMK1 (2014) (61)
- Is adrenal venous sampling necessary in all patients with hyperaldosteronism before adrenalectomy? (2008) (61)
- Expression Profiling of Difficult-to-diagnose Thyroid Histologic Subtypes Shows Distinct Expression Profiles and Identify Candidate Diagnostic microRNAs (2011) (61)
- Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma (2016) (61)
- Benign and malignant pheochromocytoma: diagnosis, treatment, and follow-Up. (1998) (61)
- Valproic acid inhibits growth, induces apoptosis, and modulates apoptosis-regulatory and differentiation gene expression in human thyroid cancer cells. (2005) (61)
- Locally advanced differentiated thyroid cancer. (2003) (61)
- Selective use of steroid replacement after adrenalectomy: lessons from 331 consecutive cases. (2006) (60)
- Curbing Unnecessary and Wasted Diagnostic Imaging. (2019) (59)
- Hyperparathyroidism-jaw tumor syndrome: Results of operative management. (2014) (59)
- Localization of Recurrent Thyroid Cancer Using Intraoperative Ultrasound-Guided Dye Injection (2009) (57)
- Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer (2015) (56)
- Patient specific tumor growth prediction using multimodal images (2014) (56)
- Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: a SNP array-based linkage analysis of 38 families. (2009) (55)
- Genome-wide methylation patterns in papillary thyroid cancer are distinct based on histological subtype and tumor genotype. (2014) (55)
- The helix-loop-helix transcription factor, Id-1, is overexpressed in medullary thyroid cancer. (2000) (55)
- Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx)-related pheochromocytoma and paraganglioma in the pediatric population (2018) (55)
- Prospective Randomized Trial of Ligasure Versus Harmonic Hemostasis Technique in Thyroidectomy (2011) (54)
- Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome. (2016) (54)
- Rate of Clinically Significant Postoperative Pancreatic Fistula in Pancreatic Neuroendocrine Tumors (2012) (54)
- Cell surface and secreted protein profiles of human thyroid cancer cell lines reveal distinct glycoprotein patterns. (2009) (54)
- Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid. (2010) (54)
- Erratum: Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma (Cancer Cell (2016) 29(5) (723–736) (S153561081630160X) (10.1016/j.ccell.2016.04.002)) (2016) (54)
- Should small papillary thyroid cancer be observed? A population‐based study (2015) (53)
- Medullary thyroid cancer (2000) (52)
- MiR-886-3p Regulates Cell Proliferation and Migration, and Is Dysregulated in Familial Non-Medullary Thyroid Cancer (2011) (52)
- The utility of 68Ga-DOTATATE positron-emission tomography/computed tomography in the diagnosis, management, follow-up and prognosis of neuroendocrine tumors. (2018) (52)
- SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma (2017) (52)
- What is the Best Criterion for the Interpretation of Adrenal Vein Sample Results in Patients with Primary Hyperaldosteronism? (2012) (52)
- Waiting for change: symptom resolution after adrenalectomy for Cushing's syndrome. (2008) (52)
- Convolutional Invasion and Expansion Networks for Tumor Growth Prediction (2018) (52)
- Prognostic Utility of Total 68Ga-DOTATATE-Avid Tumor Volume in Patients With Neuroendocrine Tumors. (2017) (50)
- Adrenal incidentaloma, borderline elevations of urine or plasma metanephrine levels, and the "subclinical" pheochromocytoma. (2007) (50)
- Pheochromocytoma Screening Initiation and Frequency in von Hippel-Lindau Syndrome. (2015) (49)
- Hereditary Non-medullary Thyroid Cancer (2008) (49)
- MicroRNAs in the thyroid. (2016) (49)
- Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors (2018) (49)
- Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases (2017) (48)
- KIAA0101 Is Overexpressed, and Promotes Growth and Invasion in Adrenal Cancer (2011) (48)
- Performance comparison of SNP detection tools with illumina exome sequencing data—an assessment using both family pedigree information and sample-matched SNP array data (2014) (48)
- miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer (2015) (48)
- Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra‐adrenal and metastatic tumors (2017) (48)
- Diagnostic and Prognostic Value of Cell-cycle Regulatory Genes in Malignant Thyroid Neoplasms (2006) (47)
- A prospective study evaluating the accuracy of using combined clinical factors and candidate diagnostic markers to refine the accuracy of thyroid fine needle aspiration biopsy. (2010) (47)
- Lysyl Oxidase (LOX) Transcriptionally Regulates SNAI2 Expression and TIMP4 Secretion in Human Cancers (2016) (47)
- A phase II trial of valproic acid in patients with advanced, radioiodine‐resistant thyroid cancers of follicular cell origin (2017) (47)
- Reactivation of the silenced thyroid hormone receptor β gene expression delays thyroid tumor progression. (2013) (47)
- Less-than-subtotal parathyroidectomy increases the risk of persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantation. (2006) (47)
- Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone co-secreting tumors in children and adolescents causing cushing syndrome: a diagnostic dilemma and how to solve it. (2015) (46)
- The Presence of SDHB Mutations Should Modify Surgical Indications for Carotid Body Paragangliomas (2014) (46)
- Parathyroid cancer. (2010) (45)
- Total Thyroidectomy or Thyroid Lobectomy in Patients with Low-risk Differentiated Thyroid Cancer: Surgical Decision Analysis of a Controversy Using a Mathematical Model (2000) (45)
- Vandetanib successfully controls medullary thyroid cancer-related Cushing syndrome in an adolescent patient. (2014) (43)
- Parathyroid carcinoma (2001) (43)
- Candidate Diagnostic Markers and Tumor Suppressor Genes for Adrenocortical Carcinoma by Expression Profile of Genes on Chromosome 11q13 (2008) (43)
- The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study (2014) (43)
- Malignant-functioning neuroendocrine tumors of the pancreas: A survival analysis. (2016) (42)
- Does Lymphadenectomy Improve Survival in Patients with Adrenocortical Carcinoma? A Population-Based Study (2016) (42)
- Sex differences in oncogenic mutational processes (2019) (41)
- Integrated analysis of genome-wide methylation and gene expression shows epigenetic regulation of CYP11B2 in aldosteronomas. (2014) (41)
- Pancreatic Tumor Growth Prediction With Elastic-Growth Decomposition, Image-Derived Motion, and FDM-FEM Coupling (2017) (41)
- Association of VHL Genotype With Pancreatic Neuroendocrine Tumor Phenotype in Patients With von Hippel–Lindau Disease (2018) (40)
- GCMB gene, a master regulator of parathyroid gland development, expression, and regulation in hyperparathyroidism. (2004) (40)
- KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn's syndrome. (2012) (39)
- Multiple endocrine neoplasia type 2 (2004) (39)
- Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms. (2005) (39)
- Response after surgical resection of metastatic pheochromocytoma and paraganglioma: can postoperative biochemical remission be predicted? (2013) (39)
- Quantitative high-throughput drug screening identifies novel classes of drugs with anticancer activity in thyroid cancer cells: opportunities for repurposing. (2012) (39)
- Intraoperative parathyroid hormone assay and parathyroid reoperations. (2003) (38)
- Predictors of Survival in Adrenocortical Carcinoma: An Analysis From the National Cancer Database (2018) (38)
- Assessment of tumor growth in pancreatic neuroendocrine tumors in von Hippel Lindau syndrome. (2014) (37)
- An in vivo mouse model of metastatic human thyroid cancer. (2014) (37)
- RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma (2016) (37)
- Id1 gene expression is up-regulated in hyperplastic and neoplastic thyroid tissue and regulates growth and differentiation in thyroid cancer cells. (2004) (36)
- ZNF367 Inhibits Cancer Progression and Is Targeted by miR-195 (2014) (36)
- Good blood pressure control on antihypertensives, not only response to spironolactone, predicts improved outcome after adrenalectomy for aldosteronoma. (2007) (35)
- Results of Screening in Familial Non-Medullary Thyroid Cancer. (2017) (35)
- Nonfunctioning parathyroid carcinoma: case report and review of literature. (2007) (35)
- Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis (2017) (34)
- Does routine consultation of thyroid fine-needle aspiration cytology change surgical management? (2007) (34)
- Tumor growth prediction with reaction-diffusion and hyperelastic biomechanical model by physiological data fusion (2015) (34)
- Anaplastic thyroid cancer: rare, fatal, and neglected. (2012) (34)
- Association between neuroendocrine tumors biomarkers and primary tumor site and disease type based on total 68Ga-DOTATATE-Avid tumor volume measurements. (2017) (33)
- Bilateral Neck Exploration in Primary Hyperparathyroidism—When Is It Selected and How Is It Performed? (2009) (32)
- Erratum: American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer (Thyroid (2012) 22:11 (1104-1139)) (2012) (32)
- Distinct genome‐wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors (2019) (32)
- A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease. (2014) (32)
- Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery (2018) (32)
- Four clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screening (2012) (31)
- Carfilzomib is an effective anticancer agent in anaplastic thyroid cancer. (2015) (30)
- Candidate Genes Associated With Malignant Pheochromocytomas by Genome-Wide Expression Profiling (2009) (30)
- Functional Imaging Signature of Patients Presenting with Polycythemia/Paraganglioma Syndromes (2017) (30)
- Limited Parathyroidectomy in Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism: A Setup for Failure (2016) (30)
- Normal thyroid pathology in patients undergoing thyroidectomy for finding a RETgene germline mutation: a report of three cases and review of the literature. (1999) (30)
- Clinical, Diagnostic, and Treatment Characteristics of SDHA-Related Metastatic Pheochromocytoma and Paraganglioma (2019) (30)
- Patterns of antibiotic prophylaxis use for thyroidectomy and parathyroidectomy: results of an international survey of endocrine surgeons. (2010) (29)
- Does the presence of additional thyroid nodules on ultrasound alter the risk of malignancy in patients with a follicular neoplasm of the thyroid? (2007) (29)
- No need to abandon unilateral parathyroid surgery. (2012) (29)
- Interleukin‐13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinoma (2012) (29)
- A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma (2020) (28)
- Long noncoding RNAs in thyroid cancer. (2019) (28)
- Indication and timing of thyroid surgery for patients with hereditary medullary thyroid cancer syndromes. (2006) (28)
- Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid Cancer (2015) (28)
- Phenylacetate inhibits growth and vascular endothelial growth factor secretion in human thyroid carcinoma cells and modulates their differentiated function. (1999) (28)
- Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinical trial (2015) (28)
- Summary statement: utility of molecular marker testing in thyroid cancer. (2010) (28)
- Observation or laparoscopic adrenalectomy for adrenal incidentaloma? A surgical decision analysis. (2006) (28)
- Preoperative Localizing Studies for Initial Parathyroidectomy in MEN1 Syndrome: Is There Any Benefit? (2012) (27)
- Altered PTEN, ATRX, CHGA, CHGB, and TP53 Expression Are Associated with Aggressive VHL-Associated Pancreatic Neuroendocrine Tumors (2013) (27)
- Diagnosis and preoperative imaging of multiple endocrine neoplasia type 2: current status and future directions (2014) (27)
- Telomere length is shorter in affected members of families with familial nonmedullary thyroid cancer. (2013) (26)
- Utility of Intraoperative Parathyroid Hormone Monitoring in Patients with Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism Undergoing Initial Parathyroidectomy (2013) (26)
- Antineoplastic effects of decitabine, an inhibitor of DNA promoter methylation, in adrenocortical carcinoma cells. (2010) (26)
- Does the 3‐gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms? (2008) (25)
- Radioguided Surgery With Gallium 68 Dotatate for Patients With Neuroendocrine Tumors (2019) (25)
- Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAF(V600E) positive papillary thyroid cancers. (2008) (25)
- Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis (2015) (24)
- Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples (2015) (24)
- Multiple genetic alterations in papillary thyroid cancer are associated with younger age at presentation. (2010) (24)
- Adrenal Histologic Findings Show No Difference in Clinical Presentation and Outcome in Primary Hyperaldosteronism (2013) (23)
- Ethnicity of Patients With Germline GCM2-Activating Variants and Primary Hyperparathyroidism (2017) (23)
- LIMD2 is a small LIM-only protein overexpressed in metastatic lesions that regulates cell motility and tumor progression by directly binding to and activating the integrin-linked kinase. (2014) (23)
- Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (22)
- Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure (2018) (22)
- Testosterone regulates thyroid cancer progression by modifying tumor suppressor genes and tumor immunity. (2015) (22)
- The Rate and Clinical Significance of Incidental Thyroid Uptake as Detected by Gallium-68 DOTATATE Positron Emission Tomography/Computed Tomography. (2016) (22)
- Executive Summary of the American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults. (2020) (22)
- Phase I trial of systemic intravenous infusion of interleukin-13-Pseudomonas exotoxin in patients with metastatic adrenocortical carcinoma (2015) (22)
- Modulation of matrix metalloproteinase activity in human thyroid cancer cell lines using demethylating agents and histone deacetylase inhibitors. (2011) (22)
- Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1. (2013) (22)
- Pros and cons of robotic transaxillary thyroidectomy. (2012) (21)
- Reoperative Surgery in Patients with Multiple Endocrine Neoplasia Type 1 Associated Primary Hyperparathyroidism (2016) (21)
- Prospective screening in familial nonmedullary thyroid cancer. (2013) (21)
- Contemporary Management of Anaplastic Thyroid Cancer (2020) (21)
- How to localize parathyroid tumors in primary hyperparathyroidism? (2006) (20)
- The helix-loop-helix protein, Id-1, is overexpressed and regulates growth in papillary thyroid cancer. (2003) (20)
- Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer (2016) (20)
- Age and tumor size predicts lymph node involvement in Hürthle Cell Carcinoma (2010) (19)
- Parathyroid carcinoma, a rare but important disorder for endocrinologists, primary care physicians, and endocrine surgeons. (2008) (19)
- Feasibility of Radio-Guided Surgery with 68Gallium-DOTATATE in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors (2015) (19)
- GSK-3β Protein Phosphorylates and Stabilizes HLXB9 Protein in Insulinoma Cells to Form a Targetable Mechanism of Controlling Insulinoma Cell Proliferation* (2014) (18)
- Malignant pheochromocytoma. (2006) (18)
- Serum RARRES2 Is a Prognostic Marker in Patients With Adrenocortical Carcinoma. (2016) (18)
- CDC23 regulates cancer cell phenotype and is overexpressed in papillary thyroid cancer. (2011) (18)
- Diagnosis of thyroid cancer: state of art. (2013) (18)
- Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease. (2011) (18)
- Lung transplantation for pulmonary metastases and radiation-induced pulmonary fibrosis after radioactive iodine ablation of extensive lung metastases from papillary thyroid carcinoma. (2007) (18)
- Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer (2019) (17)
- Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature (2017) (17)
- Neuroendocrine Tumor of the Pancreas as a Manifestation of Cowden Syndrome: A Case Report. (2016) (17)
- National Treatment Practice for Adrenocortical Carcinoma: Have they changed and have we made any progress? (2019) (16)
- Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism. (2018) (16)
- Metastatic neuroendocrine tumors of the gastrointestinal tract and pancreas: A surgeon's plea to centering attention on the liver. (2018) (16)
- Comparison of clinical and imaging features in succinate dehydrogenase-positive versus sporadic paragangliomas. (2011) (16)
- Distinct DNA methylation signatures in neuroendocrine tumors specific for primary site and inherited predisposition. (2020) (16)
- FDG PET/CT Scan and Functional Adrenal Tumors: A Pilot Study for Lateralization (2016) (16)
- von Hippel-Lindau disease-associated solid microcystic serous adenomas masquerading as pancreatic neuroendocrine neoplasms. (2012) (16)
- Adrenal Incidentaloma. (2021) (16)
- Association of Type O Blood with Pancreatic Neuroendocrine Tumors in Von Hippel–Lindau Syndrome (2012) (16)
- Personalized Pancreatic Tumor Growth Prediction via Group Learning (2017) (16)
- A Lymph Node Ratio–Based Staging Model Is Superior to the Current Staging System for Pancreatic Neuroendocrine Tumors (2018) (16)
- Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response (2018) (16)
- Loss of CPSF2 expression is associated with increased thyroid cancer cellular invasion and cancer stem cell population, and more aggressive disease. (2014) (15)
- Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness. (2019) (15)
- Preoperative 18F-FDG PET/CT in Pheochromocytomas and Paragangliomas Allows for Precision Surgery (2019) (15)
- NOP53 as A Candidate Modifier Locus for Familial Non-Medullary Thyroid Cancer (2019) (15)
- Identification of Differential Transcriptional Patterns in Primary and Secondary Hyperparathyroidism (2018) (15)
- Clinical utility of functional imaging with ¹⁸F-FDOPA in Von Hippel-Lindau syndrome. (2012) (15)
- Preoperative Imaging Features are Associated with Surgical Complications Following Carotid Body Tumor Resection (2015) (15)
- 11-Deoxycortisol may be superior to cortisol in confirming a successful adrenal vein catheterization without cosyntropin: a pilot study. (2017) (14)
- Molecular markers of adrenocortical tumors (2012) (14)
- Surgery for adrenocortical carcinoma: When and how? (2020) (14)
- Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors (2018) (14)
- Prospective evaluation of the clinical utility of 18-fluorodeoxyglucose PET CT scanning in patients with von hippel-lindau-associated pancreatic lesions. (2014) (14)
- Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment (2019) (14)
- Undertreatment of primary hyperparathyroidism in a privately insured US population: Decreasing utilization of parathyroidectomy despite expanding surgical guidelines. (2020) (14)
- In silico VHL Gene Mutation Analysis and Prognosis of Pancreatic Neuroendocrine Tumors in von Hippel–Lindau Disease (2018) (14)
- Risk of Fracture Among Older Adults With Primary Hyperparathyroidism Receiving Parathyroidectomy vs Nonoperative Management. (2021) (13)
- Age and tumor size predicts lymph node involvement in Hürthle Cell Carcinoma. (2010) (13)
- Detection of insulinoma using (68)Gallium-DOTATATE PET/CT: a case report. (2014) (13)
- Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms (2017) (13)
- 68-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumor (2018) (13)
- Patient Factors Associated With Parathyroidectomy in Older Adults With Primary Hyperparathyroidism. (2021) (12)
- Molecular pathways associated with mortality in papillary thyroid cancer. (2011) (12)
- 18F-FDG PET/CT Volumetric Parameters are Associated with Tumor Grade and Metastasis in Pancreatic Neuroendocrine Tumors in von Hippel–Lindau Disease (2016) (11)
- The utility of 68Gallium-DOTATATE PET/CT in the detection of von Hippel-Lindau disease associated tumors. (2019) (11)
- Calciphylaxis: rare but fatal. (2005) (11)
- Prospective Evaluation of the Rate and Impact of Hemolysis on Intraoperative Parathyroid Hormone (IOPTH) Assay Results (2010) (11)
- Medullary Thyroid Cancer: It is a pain in the neck? (2011) (11)
- Pancreatic Neuroendocrine Tumor Secreting Vasoactive Intestinal Peptide and Dopamine With Pulmonary Emboli: A Case Report. (2016) (11)
- Analysis of IGF and IGFBP as Prognostic Serum Biomarkers for Adrenocortical Carcinoma (2014) (11)
- Genetic and epigenetic alterations in pancreatic neuroendocrine tumors. (2020) (10)
- MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas. (2019) (10)
- Sleeping parathyroid tumor: rapid hyperfunction after removal of the dominant tumor. (2012) (10)
- Tumor Growth Prediction with Hyperelastic Biomechanical Model, Physiological Data Fusion, and Nonlinear Optimization (2014) (10)
- RTN4IP1 is down-regulated in thyroid cancer and has tumor-suppressive function. (2013) (10)
- Midkine concentrations in fine‐needle aspiration of benign and malignant thyroid nodules (2015) (10)
- Two hundred and two consecutive operations for secondary hyperparathyroidism: has medical management changed the profiles of patients requiring parathyroidectomy? (2009) (10)
- Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy. (2020) (10)
- Lipofuscin Accumulation in Cortisol-Producing Adenomas With and Without PRKACA Mutations (2017) (10)
- KCNJ 5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism : an infrequent genetic cause of Conn ’ s syndrome (2012) (10)
- A Combinatorial Strategy for Targeting BRAFV600E-Mutant Cancers with BRAFV600E Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib) (2020) (9)
- Pancreatic Tumor Growth Prediction with Multiplicative Growth and Image-Derived Motion (2015) (9)
- Biomarkers in Thyroid Tumor Research: New Diagnostic Tools and Potential Targets of Molecular-Based Therapy (2012) (9)
- Adrenocortical Carcinoma and Synchronous Malignancies (2010) (9)
- Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III) (2019) (9)
- Functional Imaging Experience in a Germline Fumarate Hydratase Mutation–Positive Patient With Pheochromocytoma and Paraganglioma (2016) (9)
- Long-Term Outcome of Bilateral Laparoscopic Adrenalectomy Measured by Disease-Specific Questionnaire in a Unique Group of Patients with Cushing’s Syndrome (2015) (9)
- Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma (2015) (9)
- Patients with differentiated thyroid cancer have a venous gradient in thyroglobulin levels (2007) (8)
- Characterizing thyroid disease and identifying barriers to care and treatment in Uganda (2012) (8)
- Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype (2018) (8)
- Frequency and consequence of the recurrent YY1 p.T372R mutation in sporadic insulinomas. (2018) (8)
- Gene-expression profiling of adrenocortical carcinoma (2009) (8)
- Total 18F-FDG PET/CT Metabolic Tumor Volume Is Associated With Postoperative Biochemical Response in Patients With Metastatic Pheochromocytomas and Paragangliomas (2016) (8)
- Prognostic Utility of 24-Hour Urinary 5-HIAA Doubling Time in Patients With Neuroendocrine Tumors. (2018) (8)
- Thyroid Cancer and Nonsteroidal Anti-Inflammatory Drug Use: A Pooled Analysis of Patients Older Than 40 Years of Age. (2015) (7)
- The number of needle passes affects the accuracy of parathyroid hormone assay with intraoperative parathyroid aspiration. (2010) (7)
- Do patients undergoing parathyroidectomy for primary hyperparathyroidism in San Francisco, CA, and Bursa, Turkey, differ? (2009) (7)
- SDHB knockout and succinate accumulation are insufficient for tumorigenesis but dual SDHB/NF1 loss yields SDHx-like pheochromocytomas (2022) (7)
- Multimodal Image Driven Patient Specific Tumor Growth Modeling (2013) (7)
- Increased Pleiotrophin Concentrations in Papillary Thyroid Cancer (2016) (7)
- Endocrine tumors associated with the vagus nerve. (2016) (7)
- Integrated Single-cell and Plasma Proteomic Modeling to Predict Surgical Site Complications: A Prospective Cohort Study (2021) (6)
- Tumor growth modeling based on dual phase CT and FDG-PET (2013) (6)
- Reply to most patients with a small papillary thyroid carcinoma enjoy an excellent prognosis and may be managed with minimally invasive therapy or active surveillance (2015) (6)
- An update on familial nonmedullary thyroid cancer (2020) (6)
- Cumulative Radiation Exposures from CT Screening and Surveillance Strategies for von Hippel-Lindau-associated Solid Pancreatic Tumors. (2019) (6)
- HABP2 Mutation and Nonmedullary Thyroid Cancer. (2015) (6)
- ATR-101 phase 1 clinical study for adrenocortical carcinoma. (2015) (6)
- Genetic testing in endocrine surgery: Opportunities for precision surgery. (2020) (6)
- The biology of thyroid oncogenesis. (2010) (6)
- Adrenal Vein Sampling to Distinguish Between Unilateral and Bilateral Primary Hyperaldosteronism: To ACTH Stimulate or Not? (2020) (6)
- GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3 (2020) (6)
- Somatic VHL Mutation in a Patient With MEN1-Associated Metastatic Pancreatic Neuroendocrine Tumor Responding to Sunitinib Treatment: A Case Report (2017) (5)
- Metastatic papillary thyroid cancer misdiagnosed as non-small [corrected] cell lung cancer. (2011) (5)
- Id1 gene expression and regulation in human thyroid tissue. (2005) (5)
- Hemolysis falsely decreases intraoperative parathyroid hormone levels. (2009) (5)
- Management of Adrenal Masses in Children and Adults (2017) (5)
- Incidence and management of postoperative hyperglycemia in patients undergoing insulinoma resection (2017) (5)
- LOX is a novel mitotic spindle-associated protein essential for mitosis (2016) (4)
- Epidural anesthesia and hypotension in pheochromocytoma and paraganglioma. (2020) (4)
- Preoperative Systemic Inflammatory Markers as Prognostic Indicators for Recurrent Adrenocortical Carcinoma (2018) (4)
- Cancer: Thyroid cancer bone metastases and high morbidity rates (2012) (4)
- Higher rate of BRAF mutation in papillary thyroid cancer over time (vol 117, pg 4390, 2011) (2015) (4)
- High prevalence of chronic kidney disease in patients with multiple endocrine neoplasia type 1 and improved kidney function after parathyroidectomy (2019) (4)
- Near-Total Thyroidectomy Could Be the Best Treatment for Thyroid Disease in Endemic Regions—Invited Critique (2004) (4)
- Preoperative systemic inflammatory markers are prognostic indicators in recurrent adrenocortical carcinoma (2019) (4)
- Germline variation of the melanocortin‐1 receptor does not explain shared risk for melanoma and thyroid cancer (2009) (4)
- Insulinoma Due to Multiple Pancreatic Microadenoma Localized by Multimodal Imaging. (2016) (4)
- Surgical Resection of Pheochromocytomas and Paragangliomas is Associated with Lower Cholesterol Levels (2020) (4)
- Risk Haplotypes Uniquely Associated with Radioiodine-Refractory Thyroid Cancer Patients of High African Ancestry. (2019) (4)
- Atlas of endocrine surgical techniques (2010) (3)
- The effect of lithium on the progression‐free and overall survival in patients with metastatic differentiated thyroid cancer undergoing radioactive iodine therapy (2018) (3)
- Which hemostatic surgical devices should be used for thyroid surgery, or should we just continue to clamp and tie? (2013) (3)
- ONCOGENE PANEL SEQUENCING ANALYSIS IDENTIFIES CANDIDATE ACTIONABLE GENES IN ADVANCED WELL-DIFFERENTIATED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS. (2019) (3)
- Exceptional response to vemurafenib and cobimetinib in anaplastic thyroid cancer 40 years after treatment for papillary thyroid cancer (2017) (3)
- Comprehensive guidance on the diagnosis and management of primary mesenchymal tumours of the thyroid gland. (2020) (3)
- 68 Gallium-DOTATATE PET/CT Scanning Results in Patients with MEN1 (2015) (2)
- Familial Non-Medullary Thyroid Cancer (2018) (2)
- Combination Therapy with Sorafenib and Vemurafenib Is Effective in Anaplastic Thyroid Cancer (2016) (2)
- Factors associated with postoperative complications and costs for adrenalectomy in benign adrenal disorders (2021) (2)
- Repurposing existing drugs for the treatment of thyroid cancer (2012) (2)
- Quantitative reverse transcription polymerase chain reaction–based detection of thyroid‐specific gene expression in fine‐needle aspirate for thyroid cancer recurrence evaluation: A case report and review of the literature (2015) (2)
- Ectopic ACTH and CRH co-secreting tumors in children and adolescents causing Cushing syndrome : a diagnostic enigma and how to solve it (2014) (2)
- Robotic posterior retroperitoneal adrenalectomy: for what benefit and at what cost?: Comment on "Robotic vs laparoscopic posterior retroperitoneal adrenalectomy". (2012) (2)
- 11. Prospective Validation of a Simple Scoring Model to Predict Single Gland Disease in Patients With Primary Hyperparathyroidism (PHPT) (2009) (2)
- Urinary Metabolomics Analyses Identify Novel Markers of Malignant Adrenocortical Neoplasms (2015) (2)
- High Total 68Ga-DOTATATE-Avid Tumor Volume (TV) is associated with low progression-free survival and high disease-specific mortality rate in patients with neuroendocrine tumors (2017) (2)
- Inhibition of survivin with YM 155 induces durable tumor response in anaplastic thyroid cancer (2015) (2)
- 30th Anniversary and The Future of Thyroid. (2019) (1)
- Follicular and Hürthle Cell Carcinoma (2017) (1)
- Prior head and neck radiation exposure is not a contraindication to minimally invasive parathyroidectomy. (2010) (1)
- Hyperparathyroidism-Jaw Tumor Syndrome: Results of surgical management (2014) (1)
- Abstract 3543:TOP2Ais a therapeutic target for adrenocortical carcinoma . (2013) (1)
- Abstract 4367: Tumor suppressor miR-30a inhibits LOX expression and progression in anaplastic thyroid cancer (2014) (1)
- SAT-568 Glutamine Metabolism Is a New Potential Therapeutic Target in Aggressive Thyroid Cancer (2019) (1)
- Updates in endocrine surgery (2004) (1)
- TLR-10 polymorphism and papillary thyroid cancer: one more SNP to consider? (2013) (1)
- Aggressive resection of neuroendocrine tumor (NET) liver metastases: NET neutral or gain? (2019) (1)
- Serous Cystadenoma of the Pancreas Causing Obstructive Jaundice in a Patient with Von Hippel-Lindau Disease (2015) (1)
- Association of parathyroidectomy with 5-year clinically significant kidney stone events in patients with primary hyperparathyroidism. (2021) (1)
- Racial disparities in the utilization of parathyroidectomy among patients with primary hyperparathyroidism: Evidence from a nationwide analysis of Medicare claims. (2021) (1)
- MicroRNA and Gene Expression Profiling in Syndromic and Sporadic Non-Functioning Pancreatic Neuroendocrine Tumors: An Integrated Analysis (2016) (1)
- ASO Author Reflections: Systemic Inflammatory Markers in Pancreatic Neuroendocrine Tumors (2018) (1)
- Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors—A Cohort Study (2021) (1)
- CpG island methylator phenotype in adrenocortical carcinoma: fact or fiction? (2013) (1)
- Pediatric vs Adult Adrenocortical Carcinoma: Different Rate of Surgical Treatment and Patient Outcome (2019) (1)
- Thyroid Cancer: Is It All in the Genes? (2018) (1)
- Helix‐loop transcription factor, Id1, is overexpressed in medullary thyroid cancer (2000) (1)
- Chapter 31 – Thyroid Oncogenesis (2005) (1)
- Multidisciplinary management of locally advanced and widely metastatic paraganglioma in a patient with life‐threatening compressive symptoms (2015) (1)
- Probability of positive genetic testing in patients diagnosed with pheochromocytoma and paraganglioma: Criteria beyond a family history. (2020) (1)
- Abstract 3098: MiRNA-145 is a master regulator of the hallmarks of thyroid cancer. (2013) (1)
- Ethnic specific differences in endocrine neoplasms: The role of susceptibility genes. (2017) (1)
- Abstract 4191: MiR-20a inhibits thyroid cancer cell growth and invasion through LIMK1. (2013) (1)
- A multicenter evaluation of near-infrared autofluorescence imaging of parathyroid glands in thyroid and parathyroid surgery. (2022) (1)
- Adverse Cardiovascular Outcomes Among Older Adults with Primary Hyperparathyroidism Treated with Parathyroidectomy vs. non-operative Management. (2022) (1)
- Limited parathyroidectomy in multiple endocrine neoplasia type 1 associated primary hyperparathyroidism: a set up for failure (2014) (1)
- Induction of apoptosis in human follicular thyroid cancer cells by the histone deacetylase inhibitors TSA and FK228 (2004) (1)
- Clinical Case Report: LECT2-Associated Adrenal Amyloidosis (2015) (1)
- Is There a Molecular Basis for Cancer Gender Disparity (2011) (1)
- Abstract 2976: Comprehensive Pan-Genomic characterization of adrenocortical carcinoma (2015) (1)
- Author Correction: Pan-cancer analysis of whole genomes (2023) (1)
- Abstract LB-249: Reduced expression of the long non-coding RNA MEG3 in sporadic and MEN1-associated tumors. (2013) (1)
- Epidemiology of Adrenal Neoplasms (2017) (1)
- Familial Nonmedullary Thyroid Cancer (2021) (1)
- Altered PTEN, CHGA, CHGB and ATRX expression are associated with aggressive Von Hippel- Lindau-associated pancreatic neuroendocrine tumors (2012) (0)
- QS137. Have Improvements in Medical Management Changed the Profiles of Patients Undergoing Parathyroidectomy for Secondary Hyperparathyroidism (2009) (0)
- New genomic somatic amplifications and deletions in papillary thyroid cancer (2015) (0)
- Secondary and Tertiary Hyperparathyroidism (2011) (0)
- Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (0)
- Germline mutations in KIF1B gene in two families with familial non-medullary thyroid cancer (FNMTC) (2018) (0)
- SUN-115 Distinct DNA Methylation Signature in Neuroendocrine Tumors of Different Primary Sites and Hereditary Predisposition (2020) (0)
- Variations on a Theme: Comment on “Variant Adrenal Venous Anatomy in 546 Laparoscopic Adrenalectomies” (2013) (0)
- VHL Genotype and risk stratification of pancreatic neuroendocrine tumors in patients with von hippel-lindau disease (2017) (0)
- Abstract 5646: Germline activating mutations in the proto-oncogeneGCM2in primary hyperparathyroidism (2017) (0)
- von Hippel-Lindau disease-associated solid microcystic serous adenomas masquerading as pancreatic neuroendocrine tumors (2012) (0)
- PRKACA defects and cortisol-producing lesions of the adrenal cortex: specific clinical phenotypes and histological features (2015) (0)
- SUN-349 Prognostic Metabolic Signature in Aggressive Adrenocortical Carcinoma (2019) (0)
- Chapter-23 Adrenal Metastasectomy (2017) (0)
- Risk of permanent hypoparathyroidism requiring calcitriol therapy in a population-based cohort of adults older than 65 undergoing total thyroidectomy for Graves' disease. (2022) (0)
- Increased Risk of Complications Associated With Concurrent Parathyroidectomy in Patients Undergoing Total Thyroidectomy. (2023) (0)
- Novel Proteasome Inhibitor Carfilzomib in Combination with Survivin Inhibitor YM155 Induces Enhanced Cytotoxicity in Anaplastic Thyroid Cancer (2014) (0)
- P56: Expression profile of genes on chromosome 11q13 identify candidate markers of adrenocortical carcinoma and possible tumor suppressor genes (2007) (0)
- To the editor (2017) (0)
- Personalizing Thyroid Cancer Care: Are We There Yet? (2011) (0)
- Just a Little Bit of Anaplastic Thyroid Cancer? (2022) (0)
- Do preoperative imaging features predict surgical complications of carotid body tumors (2014) (0)
- Abstract 3578: Novel insights into the cellular function and gene regulation of a master mutator, APOBEC3B (2016) (0)
- Introduction to Papers Presented at the Orlo H. Clark Festschrift (2009) (0)
- CBDC-Project Ethiopia. Report on the discussion concerning collaboration between the Ethiopia-CBDC-Project and IT Programme, June 6, 1996 (1996) (0)
- Thyroid 2020 to 2021. (2020) (0)
- Programmed Death-Ligand 1 as a prognostic marker in papillary thyroid cancer (2013) (0)
- Abstract 2727: LOX is a novel mitotic spindle-associated protein essential for mitosis (2016) (0)
- A Multidisciplinary journal focused on endocrine oncology (2014) (0)
- Molecular and Cellular Pathobiology LIMD 2 Is a Small LIM-Only Protein Overexpressed in Metastatic Lesions That Regulates Cell Motility and Tumor Progression by Directly Binding to and Activating the Integrin-Linked Kinase (2014) (0)
- MicroRNA profiling of benign and malignant pheochromocytomas (2011) (0)
- When and how should we perform extensive surgery (2017) (0)
- Who Should Have Genetic Testing in Primary Hyperparathyroidism to Optimize Surgical Management (2017) (0)
- The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study (2014) (0)
- Abstract 176: Generation and maintenance of anaplastic thyroid cancer spheroids from human cancer cells (2023) (0)
- Authors’ Reply (2011) (0)
- Should small thyroid cancer be observed? A population-based study of non-medullary thyroid cancer-related mortality (2014) (0)
- The peroxisome proliferator-activated receptor gamma agonist rosiglitazone inhibits growth and downregulates Bcl-2 gene expression in human follicular thyroid cancer cells (2004) (0)
- CDC 23 regulates cancer cell phenotype and is overexpressed in papillary thyroid cancer (2011) (0)
- Relacorilant With Pembrolizumab: A Phase 1b, Open-Label Study of a Selective Glucocorticoid Receptor Modulator Combined With a Checkpoint Inhibitor for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production (2021) (0)
- Nile red staining helps select cells with adrenocortical progenitor cell-like phenotype. (2010) (0)
- Abstract 3664: RARRES2 functions as a direct tumor suppressor by promoting beta-catenin phosphorylation and degradation independent of CMKLR1 and CMKLR1-mediated antitumor immune response in adrenocortical carcinoma (2016) (0)
- Editorial: Translational Research in Thyroid Cancer (2020) (0)
- To the editor (2017) (0)
- Abstract 5219: The LIM protein LIMD2 functions as an effector and biomarker for metastasis in multiple tumor types (2011) (0)
- Atlas of Endocrine Surgical Techniques, 1st edn (2010) (0)
- Clinical trial enrollment in patients with endocrine neoplasm: Parity achievable, but cancer type-specific. (2019) (0)
- Reply: Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment. (2019) (0)
- American Association of Endocrine Surgeons Molecular pathways associated with mortality in papillary thyroid cancer (2011) (0)
- Solutions to Reduce Unnecessary Imaging-Reply. (2019) (0)
- A Contemporary Review of the Treatment of Medullary Thyroid Carcinoma in the Era of New Drug Therapies (2023) (0)
- Neural monitoring in endocrine neck surgery. (2018) (0)
- from the editor (1989) (0)
- Prior Radiation Is Not a Contraindication to Minimally Invasive Parathyroidectomy (2010) (0)
- List of Contributors (2020) (0)
- Erratum: A prospective study evaluating the accuracy of using combined clinical factors and candidate diagnostic markers to refine the accuracy of thyroid fine needle aspiration biopsy (Surgery (2010) 148:6 (1170-1177)) (2012) (0)
- Multimodal Image Driven Pancreatic Tumor Growth Prediction (2014) (0)
- Treatment for Advanced and Metastatic Thyroid Cancer Refractory to Standard Treatment-We Need to Know the When, What, and Who. (2021) (0)
- 183. A Molecular Rationale for Gender-Specific Differences in the Prognosis of Papillary Thyroid Cancer (2009) (0)
- Estimated Effect of Parathyroidectomy on Long-Term Kidney Function in Adults With Primary Hyperparathyroidism (2023) (0)
- Multiple Endocrine Neoplasia Type 2a and 2b (2021) (0)
- Four clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screening (2012) (0)
- QS124. Is Serum Thyroglobulin Accurate as a Preoperative Biomarker of Malignancy in Follicular and Hürthle-Cell Neoplasms of the Thyroid? (2009) (0)
- 178. Microrna Profiling in Pheochromocytoma (2009) (0)
- In Memoriam: Orlo H. Clark, MD (1941-2022). (2023) (0)
- SUN-553 Atypical Spindle Cells on a Thyroid Aspirate: A Rare Case of a Thyroid Schwannoma Presenting as a Progressively Expanding Thyroid Nodule (2019) (0)
- National Treatment Trends for Adrenocortical Cancer in the US: Have We Made Any Progress? (2018) (0)
- Adrenal Incidentaloma. Reply. (2021) (0)
- Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia (2014) (0)
- Management of aggressive variants and anaplastic thyroid cancers (2011) (0)
- Abstract 992: LIMD2 is a small LIM-only protein overexpressed in metastatic lesions which regulates cell motility and tumor progression by directly binding to and activating the integrin-linked-kinase (2014) (0)
- Preoperative Genetic Testing and 18 Fluorine-Fludeoxyglucose PET/CT Imaging in Pheochromocytomas and Paragangliomas Allow for Precision Surgery (2017) (0)
- Author Correction: Patterns of somatic structural variation in human cancer genomes (2020) (0)
- 179. Prospective Evaluation of the Rate and Impact of Hemolysis on Intraoperative Parathyroid Hormone Assay (IOPTH) Results (2009) (0)
- Four-Gland Exploration Versus Focused Parathyroidectomy for Hyperparathyroidism Jaw Tumor Syndrome (2018) (0)
- This Year in Thyroid and Farewell. (2021) (0)
- Superiorityof [ 68 Ga ]-DOTATATEPET / CTtoOther Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma (2015) (0)
- A Co-Occurrence of Familial Non-Medullary Thyroid Cancer and Lynch Syndrome (2021) (0)
- Tumor growth in von Hippel Lindau syndrome: in reply to Qazi and colleagues. (2015) (0)
- QS123. Young Age at Diagnosis of Papillary Thyroid Cancer is Associated With the Presence of Multiple Somatic Mutations (2009) (0)
- Detection of Grade 2/3 Von Hippel-Lindau Associated Pancreatic Lesions by 18-FDG PET/CT Volumetric Parameters (2015) (0)
- Abstract 3041: Differential expression of microRNAs between sporadic and hereditary nonmedullary thyroid cancer (2010) (0)
- Radio-Guided Surgery with 68Gallium-DOTATATE in Patients with Neuroendocrine Tumors (2018) (0)
- Chapter-044 Oncogenesis and New Targeted Treatment for Thyroid Cancer (2016) (0)
- 33: Markers of malignant phenotype in pheochromocytomas by gene expression profiling (2007) (0)
- Tumor Growth Prediction Using Convolutional Networks (2019) (0)
- Abstract 3932: IL13Rα2 regulates cell invasion, and is a therapeutic target for adrenocortical carcinoma (2012) (0)
- Reticulon 4 Interacting Protein 1 (RTN4IP1) Regulates Cancer Cell Phenotype and is Downregulated in Papillary Thyroid Cancer (2012) (0)
- Author Correction: Inferring structural variant cancer cell fraction (2022) (0)
- Resection of the Primary Tumor in Patients with Distant Thyroid Cancer Metastasis Is Associated with Longer Survival (2019) (0)
- Lymph Node Ratio (LNR) Is a Superior Prognostic Factor to Nodal Positivity for Pancreatic Neuroendocrine Tumors (2017) (0)
- Kidney stone events following parathyroidectomy vs. non-operative management for primary hyperparathyroidism. (2022) (0)
- 24 hour urinary 5-hydroxyindoleacetic acid (5-HIAA) doubling-time (DT) is associated with disease-specific mortality (DSM) and progression-free survival (PFS) in patients with neuroendocrine tumors (NETs) (2017) (0)
- Author Correction: The evolutionary history of 2,658 cancers (2023) (0)
- Thyroid intake form MULAGO Hospital Breast and Endocrine Surgical Unit Thyroid Intake Form (2012) (0)
- Variations on a theme. Variant venous adrenal anatomy at work. (2013) (0)
- Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors (2018) (0)
- Multiple Endocrine Neoplasia Type 2B (2020) (0)
- QS136. KIAA0101 is Overexpressed in Adrenocortical Carcinoma and Regulates Cell Growth (2009) (0)
This paper list is powered by the following services:
Other Resources About Electron Kebebew
What Schools Are Affiliated With Electron Kebebew?
Electron Kebebew is affiliated with the following schools:
